Literature DB >> 18844788

The Utah Early Neuropathy Scale: a sensitive clinical scale for early sensory predominant neuropathy.

J Robinson Singleton1, Billie Bixby, James W Russell, Eva L Feldman, Amanda Peltier, Jonathan Goldstein, James Howard, A Gordon Smith.   

Abstract

Early neuropathy is often sensory predominant and prominently involves small-diameter nerve fibers. Established neuropathy examination scales such as the Michigan Diabetic Neuropathy Scale (MDNS) and the Neuropathy Impairment Score-Lower Leg (NIS-LL) focus primarily on large-fiber sensory and motor function. Here, we validate the Utah Early Neuropathy Scale (UENS), a physical examination scale specific to early sensory predominant polyneuropathy. Compared with other scales, the UENS emphasizes severity and spatial distribution of pin (sharp) sensation loss in the foot and leg and focuses less on motor weakness. UENS, MDNS, and NIS-LL were compared in 215 diabetic or prediabetic subjects, with (129) or without neuropathy (86), and repeated in 114 neuropathy subjects after 1 year of follow-up. Neuropathy severity was also evaluated with nerve conduction studies, quantitative sensory testing, quantitative sudomotor axonal reflex testing, and intraepidermal nerve fiber density determination. The UENS had a high degree of interrater reliability (interclass correlation of 94%). UENS correlated significantly to MDNS and NIS-LL (p < 0.01), and more significantly than MDNS or NIS-LL to confirmatory tests. In this cohort, UENS had a superior profile to receiver operating characteristic analysis across a range of scores, with a sensitivity (92%) higher than MDNS (67%) or NIS-LL (81%), without sacrificing specificity. UENS more closely correlated with change in ancillary and small-fiber neuropathy measures over 1 year follow-up than did MDNS or NIS-LL. UENS is a sensitive and reproducible clinical measure of sensory and small-fiber nerve injury and may be useful in trials of early neuropathy.

Entities:  

Mesh:

Year:  2008        PMID: 18844788     DOI: 10.1111/j.1529-8027.2008.00180.x

Source DB:  PubMed          Journal:  J Peripher Nerv Syst        ISSN: 1085-9489            Impact factor:   3.494


  63 in total

1.  Assessing autonomic dysfunction in early diabetic neuropathy: the Survey of Autonomic Symptoms.

Authors:  L Zilliox; A C Peltier; P A Wren; A Anderson; A G Smith; J R Singleton; E L Feldman; N B Alexander; J W Russell
Journal:  Neurology       Date:  2011-03-22       Impact factor: 9.910

Review 2.  Diagnosis and treatment of pain in small-fiber neuropathy.

Authors:  Alexandra Hovaguimian; Christopher H Gibbons
Journal:  Curr Pain Headache Rep       Date:  2011-06

3.  Factors associated with distal symmetric polyneuropathies in adult Zambians: A cross-sectional, observational study of the role of HIV, non-antiretroviral medication exposures, and nutrition.

Authors:  Michelle Kvalsund; Takondwa Chidumayo; Johanna Hamel; David Herrmann; Douglas Heimburger; Amanda Peltier; Gretchen Birbeck
Journal:  J Neurol Sci       Date:  2018-02-22       Impact factor: 3.181

4.  Wireless transcutaneous electrical nerve stimulation device for chemotherapy-induced peripheral neuropathy: an open-label feasibility study.

Authors:  Jennifer S Gewandter; Jenna Chaudari; Chinazom Ibegbu; Rachel Kitt; Jennifer Serventi; Joy Burke; Eva Culakova; Noah Kolb; Kathleen A Sluka; Mohamedtaki A Tejani; Nimish A Mohile
Journal:  Support Care Cancer       Date:  2018-08-27       Impact factor: 3.603

Review 5.  Diabetic neuropathy part 1: overview and symmetric phenotypes.

Authors:  Mamatha Pasnoor; Mazen M Dimachkie; Patricia Kluding; Richard J Barohn
Journal:  Neurol Clin       Date:  2013-03-15       Impact factor: 3.806

6.  Activity for Diabetic Polyneuropathy (ADAPT): Study Design and Protocol for a 2-Site Randomized Controlled Trial.

Authors:  Patricia M Kluding; J Robinson Singleton; Mamatha Pasnoor; Mazen M Dimachkie; Richard J Barohn; A Gordon Smith; Robin L Marcus
Journal:  Phys Ther       Date:  2017-01-01

7.  Small-fiber degeneration in alcohol-related peripheral neuropathy.

Authors:  Michelle L Mellion; Elizabeth Silbermann; James M Gilchrist; Jason T Machan; Lorenzo Leggio; Suzanne de la Monte
Journal:  Alcohol Clin Exp Res       Date:  2014-06-24       Impact factor: 3.455

8.  Quick, non-invasive and quantitative assessment of small fiber neuropathy in patients receiving chemotherapy.

Authors:  Mehdi Saad; Dimitri Psimaras; Camille Tafani; Magali Sallansonnet-Froment; Jean-Henri Calvet; Alice Vilier; Jean-Marie Tigaud; Flavie Bompaire; Marie Lebouteux; Thierry de Greslan; Bernard Ceccaldi; Jean-Michel Poirier; François-Régis Ferrand; Sylvestre Le Moulec; Olivier Huillard; François Goldwasser; Hervé Taillia; Thierry Maisonobe; Damien Ricard
Journal:  J Neurooncol       Date:  2016-01-09       Impact factor: 4.130

9.  Increased axonal regeneration and swellings in intraepidermal nerve fibers characterize painful phenotypes of diabetic neuropathy.

Authors:  Hsinlin T Cheng; Jacqueline R Dauch; Michael T Porzio; Brandon M Yanik; Wilson Hsieh; A Gordon Smith; J Robinson Singleton; Eva L Feldman
Journal:  J Pain       Date:  2013-05-17       Impact factor: 5.820

10.  Association of comorbidities with increasing severity of peripheral neuropathy in diabetes mellitus.

Authors:  Shafina Sachedina; Cory Toth
Journal:  World J Diabetes       Date:  2013-08-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.